BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 24615674)

  • 1. ADAMTS-13 content of plasma-derived factor VIII/ von Willebrand factor concentrates.
    Kingsland S; Feldman P
    Am J Hematol; 2014 Jun; 89(6):667-8. PubMed ID: 24615674
    [No Abstract]   [Full Text] [Related]  

  • 2. ADAMTS13 content in plasma-derived factor VIII/von Willebrand factor concentrates.
    Peyvandi F; Mannucci PM; Valsecchi C; Pontiggia S; Farina C; Retzios AD
    Am J Hematol; 2013 Oct; 88(10):895-8. PubMed ID: 23813910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative and qualitative analysis of coagulation factors in cryoprecipitate prepared from fresh-frozen plasma inactivated with amotosalen and ultraviolet A light.
    Cid J; Caballo C; Pino M; Galan AM; Martínez N; Escolar G; Diaz-Ricart M
    Transfusion; 2013 Mar; 53(3):600-5. PubMed ID: 22738354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ADAMTS-13 activity and von Willebrand factor levels in methylene-blue photo-inactivated plasma processed by either the Springe method or an 'in house' system.
    del Río-Garma J; Pereira A; Arroyo JL; Mateo J; Alvarez-Larrán A; Martínez C; Muncunill J; Barbolla L;
    Vox Sang; 2008 Aug; 95(2):101-5. PubMed ID: 18557825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Von Willebrand factor multimers in virus-inactivated plasmas and F VIII concentrates.
    Budde U; Drewke E
    Beitr Infusionsther Transfusionsmed; 1994; 32():408-14. PubMed ID: 9422121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Standards for assay of von Willebrand factor concentrates: a collaborative study.
    Fricke WA; Lamb MA; Rastogi SC
    Thromb Haemost; 1993 Aug; 70(2):351-6. PubMed ID: 8236147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Von Willebrand Factor (VIIIVWF) in lyophilized Factor VIII concentrates.
    McCue MJ; Brossoit AD; Marmer DJ; Head DR
    Am J Hematol; 1980; 9(1):39-42. PubMed ID: 6776806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative analysis and classification of von Willebrand factor/factor VIII concentrates: impact on treatment of patients with von Willebrand disease.
    Budde U; Metzner HJ; Müller HG
    Semin Thromb Hemost; 2006 Sep; 32(6):626-35. PubMed ID: 16977573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma levels of von Willebrand factor regulate ADAMTS-13, its major cleaving protease.
    Mannucci PM; Capoferri C; Canciani MT
    Br J Haematol; 2004 Jul; 126(2):213-8. PubMed ID: 15238142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Von Willebrand factor/factor VIII concentrates in the treatment of von Willebrand disease.
    Batlle J; López-Fernández MF; Fraga EL; Trillo AR; Pérez-Rodríguez MA
    Blood Coagul Fibrinolysis; 2009 Mar; 20(2):89-100. PubMed ID: 19786936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in von Willebrand factor and ADAMTS13 during IVF.
    Westerlund E; Antovic A; Hovatta O; Eberg KP; Blombäck M; Wallén H; Henriksson P
    Blood Coagul Fibrinolysis; 2011 Mar; 22(2):127-31. PubMed ID: 21192251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma levels of von Willebrand factor, von Willebrand factor propeptide and factor VIII in carriers and patients with nephrogenic diabetes insipidus.
    Nossent AY; Ellenbroek JH; Frölich M; Bertina RM; Knoers NV; Eikenboom JC
    Thromb Res; 2010 Jun; 125(6):554-6. PubMed ID: 20430418
    [No Abstract]   [Full Text] [Related]  

  • 13. Variant von Willebrand's disease: characterization of two subtypes by analysis of multimeric composition of factor VIII/von Willebrand factor in plasma and platelets.
    Ruggeri ZM; Zimmerman TS
    J Clin Invest; 1980 Jun; 65(6):1318-25. PubMed ID: 6773982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationships between factor VIII:Ag and factor VIII in recombinant and plasma-derived factor VIII concentrates.
    Lin Y; Yang X; Chevrier MC; Craven S; Barrowcliffe TW; Lemieux R; Ofosu FA
    Haemophilia; 2004 Sep; 10(5):459-69. PubMed ID: 15357771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. von Willebrand factor contained in factor VIII concentrates of different purities supports platelet adhesion in blood samples from a heterogeneous group of patients with von Willebrand disease.
    Escolar G; Carretero M; Magallón M; Quintana M; Arnau C; Castillo R; Aznar-Salatti J
    Haematologica; 1998 Nov; 83(11):1009-14. PubMed ID: 9864923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Standardisation of factor VIII--V. Calibration of the 2nd International Standard for Factor VIII and von Willebrand factor activities in plasma.
    Heath AB; Barrowcliffe TW
    Thromb Haemost; 1992 Aug; 68(2):155-9. PubMed ID: 1412160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of proteases in AHF concentrates: effect on factor VIII:von Willebrand protein as assessed by high-pressure gel permeation chromatography.
    Orthner CL
    J Lab Clin Med; 1984 Nov; 104(5):816-28. PubMed ID: 6436416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Studies on the dynamics of plasma factor VIII/von Willebrand factor activity in cerebrovascular diseases].
    Shinmyozu K; Maruyama Y; Ohkatsu Y; Maruyama I; Igata A
    Rinsho Shinkeigaku; 1983 Feb; 23(2):172-9. PubMed ID: 6407797
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparison of two von Willebrand factor collagen-binding assays with different binding affinities for low, medium, and high multimers of von Willebrand factor.
    Neugebauer BM; Goy C; Budek I; Seitz R
    Semin Thromb Hemost; 2002 Apr; 28(2):139-48. PubMed ID: 11992237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Sugar-chain of factor VIII/von Willebrand factor in von Willebrand's disease. Analysis by immuno-affinoelectrophoresis using lectin].
    Ueda M; Yasui M; Nishino M; Mikami S; Fukui H
    Nihon Ketsueki Gakkai Zasshi; 1983 Sep; 46(5):1117-23. PubMed ID: 6421045
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.